Tags

Type your tag names separated by a space and hit enter

Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016.
MMWR Morb Mortal Wkly Rep 2016; 65(5):120-1MM

Abstract

Zika virus is a mosquito-borne flavivirus primarily transmitted by Aedes aegypti mosquitoes (1,2). Infection with Zika virus is asymptomatic in an estimated 80% of cases (2,3), and when Zika virus does cause illness, symptoms are generally mild and self-limited. Recent evidence suggests a possible association between maternal Zika virus infection and adverse fetal outcomes, such as congenital microcephaly (4,5), as well as a possible association with Guillain-Barré syndrome. Currently, no vaccine or medication exists to prevent or treat Zika virus infection. Persons residing in or traveling to areas of active Zika virus transmission should take steps to prevent Zika virus infection through prevention of mosquito bites (http://www.cdc.gov/zika/prevention/).

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26866485

Citation

Oster, Alexandra M., et al. "Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016." MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 5, 2016, pp. 120-1.
Oster AM, Brooks JT, Stryker JE, et al. Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(5):120-1.
Oster, A. M., Brooks, J. T., Stryker, J. E., Kachur, R. E., Mead, P., Pesik, N. T., & Petersen, L. R. (2016). Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 65(5), pp. 120-1. doi:10.15585/mmwr.mm6505e1.
Oster AM, et al. Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016 Feb 12;65(5):120-1. PubMed PMID: 26866485.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Interim Guidelines for Prevention of Sexual Transmission of Zika Virus - United States, 2016. AU - Oster,Alexandra M, AU - Brooks,John T, AU - Stryker,Jo Ellen, AU - Kachur,Rachel E, AU - Mead,Paul, AU - Pesik,Nicki T, AU - Petersen,Lyle R, Y1 - 2016/02/12/ PY - 2016/2/12/entrez PY - 2016/2/13/pubmed PY - 2016/6/14/medline SP - 120 EP - 1 JF - MMWR. Morbidity and mortality weekly report JO - MMWR Morb. Mortal. Wkly. Rep. VL - 65 IS - 5 N2 - Zika virus is a mosquito-borne flavivirus primarily transmitted by Aedes aegypti mosquitoes (1,2). Infection with Zika virus is asymptomatic in an estimated 80% of cases (2,3), and when Zika virus does cause illness, symptoms are generally mild and self-limited. Recent evidence suggests a possible association between maternal Zika virus infection and adverse fetal outcomes, such as congenital microcephaly (4,5), as well as a possible association with Guillain-Barré syndrome. Currently, no vaccine or medication exists to prevent or treat Zika virus infection. Persons residing in or traveling to areas of active Zika virus transmission should take steps to prevent Zika virus infection through prevention of mosquito bites (http://www.cdc.gov/zika/prevention/). SN - 1545-861X UR - https://www.unboundmedicine.com/medline/citation/26866485/Interim_Guidelines_for_Prevention_of_Sexual_Transmission_of_Zika_Virus___United_States_2016_ L2 - https://dx.doi.org/10.15585/mmwr.mm6505e1 DB - PRIME DP - Unbound Medicine ER -